Endocrine Pharmacology Practice Questions

Q: All of the following are true regarding the use of iodine, except:

Its use is contraindicated in hyperthyroidism.. **Explanation:** The correct answer is **D**, as iodine is **not** contraindicated in hyperthyroidism; rather, it is used strategically in specific clinical scenarios. **1. Why Option D is the correct answer (The Exception):** Iodine (usually as Lugol’s iodine or potassium iodide) is a standard treatment for hyperthyroidism in two specific cases: **Pre-operative preparation** for thyroidectomy (to decrease the vascularity and size of the gland) and **Thyroid Storm** (to rapidly block hormone release). Therefore, stating it is contraindicated is medically incorrect. **2. Analysis of other options:** * **Option A (True):** High doses of iodine acutely inhibit the proteolysis of thyroglobulin, thereby blocking the **release** of T3 and T4 into the circulation. This is the fastest-acting mechanism to lower thyroid levels. * **Option B (True):** This refers to the **Wolff-Chaikoff effect**, where high plasma iodide concentrations cause a transient inhibition of the organic binding of iodine (organification), stopping the synthesis of iodotyrosine and iodothyronine. * **Option C (True):** **Iodism** is a chronic toxicity resulting from iodine use. Symptoms include a metallic taste, burning sensation in the mouth, sneezing (coryza), and swelling of the eyelids/salivary glands. **Clinical Pearls for NEET-PG:** * **The Escape Phenomenon:** The Wolff-Chaikoff effect is transient; the thyroid "escapes" this inhibition after 10–14 days. Thus, iodine should not be used as long-term monotherapy. * **Jod-Basedow Phenomenon:** In contrast to the Wolff-Chaikoff effect, iodine administration in a deficient patient can sometimes *induce* hyperthyroidism. * **Amiodarone:** This antiarrhythmic drug contains high iodine content and can cause both hyper- and hypothyroidism.

Q: Flushing is common in patients taking which of the following oral hypoglycemic drugs with alcohol?

Chlorpropamide. ### Explanation **1. Why Chlorpropamide is Correct:** Chlorpropamide is a first-generation sulfonylurea known for causing a **Disulfiram-like reaction** when consumed with alcohol. This occurs because chlorpropamide inhibits the enzyme **aldehyde dehydrogenase**, leading to the accumulation of acetaldehyde in the blood. High levels of acetaldehyde trigger systemic vasodilation, resulting in symptoms such as intense flushing (especially of the face), nausea, tachycardia, and headache. This specific phenomenon is often referred to as **Chlorpropamide-Alcohol Flush (CPAF)**. **2. Why the Other Options are Incorrect:** * **Phenformin (B):** This is a biguanide (like metformin) that was withdrawn from the market primarily due to a high risk of **lactic acidosis**. While it interacts with alcohol to increase lactic acid levels, it does not typically cause a disulfiram-like flushing reaction. * **Glibenclamide (C) & Tolazamide (D):** These are second-generation and first-generation sulfonylureas, respectively. While all sulfonylureas can theoretically cause mild disulfiram-like reactions, the incidence is significantly lower than with chlorpropamide. Glibenclamide, in particular, has a very low propensity for this side effect. **3. High-Yield Clinical Pearls for NEET-PG:** * **Chlorpropamide** has the longest half-life among sulfonylureas (~36 hours) and is most likely to cause **SIADH** (dilutional hyponatremia) and prolonged hypoglycemia. * **Other drugs causing Disulfiram-like reactions:** Metronidazole (most common), Tinidazole, Griseofulvin, Cefotetan, and Procarbazine. * **Management:** The reaction is self-limiting; the primary management is avoidance of alcohol while on these medications.

Q: Which dopamine agonist is used in the management of diabetes mellitus?

Bromocriptine. **Explanation:** **Bromocriptine** is a potent dopamine D2 receptor agonist. While primarily known for treating hyperprolactinemia and Parkinson’s disease, a specific quick-release (QR) formulation of Bromocriptine is FDA-approved for the management of **Type 2 Diabetes Mellitus**. **Mechanism of Action:** In patients with Type 2 DM, there is often a decrease in dopaminergic tone in the hypothalamus during the morning. Bromocriptine QR, when administered within two hours of waking, acts on the circadian rhythm to increase hypothalamic dopaminergic activity. This results in a reduction of sympathetic outflow, leading to decreased hepatic glucose production (gluconeogenesis), reduced insulin resistance, and lower free fatty acid levels without increasing insulin secretion. **Analysis of Incorrect Options:** * **A. Metformin:** This is a Biguanide, not a dopamine agonist. It is the first-line drug for Type 2 DM, acting primarily by activating AMPK to inhibit hepatic gluconeogenesis. * **C. Cabergoline:** Although it is a long-acting dopamine agonist used for prolactinomas, it is **not** approved or used for the management of glycemic control in diabetes. * **D. Vanadium salts:** These are trace elements that have "insulin-mimetic" properties but are not dopamine agonists and are not used in standard clinical practice due to toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Bromocriptine QR** is the only dopamine agonist approved for DM. * It does **not** cause hypoglycemia or weight gain, making it unique among many oral hypoglycemics. * It is also known to reduce the risk of major adverse cardiovascular events (MACE). * **Side effects:** Nausea, dizziness, and orthostatic hypotension are common during initiation.

Q: Which of the sulfonylureas is the best choice in patients with chronic kidney disease?

Glipizide. **Explanation:** The primary concern when using sulfonylureas in patients with chronic kidney disease (CKD) is the risk of **severe, prolonged hypoglycemia**. This occurs because many sulfonylureas or their active metabolites are excreted renally. [1] **Why Glipizide is the Correct Choice:** Glipizide is considered the safest sulfonylurea in CKD because it is primarily metabolized by the **liver** into **inactive metabolites**. These inactive metabolites are then excreted in the urine, posing no risk of hypoglycemia even if they accumulate due to a low Glomerular Filtration Rate (GFR). It also has a shorter half-life compared to other agents in its class. **Analysis of Incorrect Options:** * **Glibenclamide (Glyburide):** These are the same drug (Option B and D). It is **contraindicated** in CKD (especially if GFR <60 mL/min). It has active metabolites that are cleared by the kidneys; accumulation leads to profound, life-threatening hypoglycemia. * **Glimepiride:** While it is a second/third-generation agent, it possesses active metabolites that are renally cleared. It should be used with extreme caution or avoided in advanced CKD. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** While Glipizide is the best *sulfonylurea* for CKD, the overall oral hypoglycemic agent of choice in advanced CKD is typically a **DPP-4 inhibitor** (like Linagliptin, which requires no renal adjustment) or **Insulin**. [2] * **Metformin:** Must be discontinued if **eGFR <30 mL/min** due to the risk of lactic acidosis. [1] * **Gliclazide:** Another preferred sulfonylurea in mild-to-moderate CKD as it has inactive metabolites, but Glipizide remains the classic textbook answer for safety. * **Rule of Thumb:** "Glipizide stays in the liver, Glyburide gets stuck in the kidney."

Q: Which of the following is an anti-progesterone drug?

Mifepristone. **Explanation:** **Mifepristone (RU-486)** is the correct answer because it is a potent **competitive progesterone receptor antagonist**. It binds to progesterone receptors with higher affinity than endogenous progesterone, preventing the hormone from maintaining the decidua. This leads to the detachment of the blastocyst and sensitization of the uterus to prostaglandins. **Analysis of Incorrect Options:** * **Cyproterone:** This is an **anti-androgen** (androgen receptor antagonist) with weak progestational activity. It is used in the management of hirsutism, acne, and precocious puberty. * **Spironolactone:** Primarily a potassium-sparing diuretic, it also acts as an **aldosterone antagonist** and has significant anti-androgenic properties. It is not an anti-progestin. * **Tamoxifen:** This is a **Selective Estrogen Receptor Modulator (SERM)**. It acts as an antagonist in the breast (used in breast cancer) but as an agonist in the bone and endometrium. **High-Yield Clinical Pearls for NEET-PG:** * **Medical Abortion Regimen:** Mifepristone (200 mg orally) is followed 36–48 hours later by **Misoprostol** (400–800 mcg) to induce uterine contractions. This is effective up to 7-9 weeks of gestation. * **Cushing’s Syndrome:** Mifepristone is also FDA-approved for controlling hyperglycemia in patients with endogenous Cushing’s syndrome (due to its **glucocorticoid receptor antagonism** at high doses). * **Emergency Contraception:** Mifepristone can be used as a single dose for emergency contraception (though Levonorgestrel and Ulipristal are more common). * **Ulipristal:** Another important Selective Progesterone Receptor Modulator (SPRM) used for emergency contraception and uterine fibroids.

Q: Which antidiabetic drug acts independently of insulin?

SGLT2 inhibitor. The correct answer is **A. SGLT2 inhibitor** (e.g., Dapagliflozin, Empagliflozin). **Mechanism of Action:** SGLT2 inhibitors act on the proximal convoluted tubule (PCT) of the kidney to inhibit the Sodium-Glucose Co-transporter 2. This prevents the reabsorption of filtered glucose, leading to **glycosuria** (excretion of glucose in the urine). Because this process depends entirely on the renal filtration of glucose and not on pancreatic function or peripheral insulin sensitivity, it is considered **insulin-independent**. This makes them effective even in patients with long-standing Type 2 Diabetes who have significant beta-cell exhaustion. **Why the other options are incorrect:** * **B. DPP4 inhibitors** (e.g., Sitagliptin) and **D. GLP1 agonists** (e.g., Liraglutide) are incretin-based therapies. They work by stimulating the pancreas to release insulin in a glucose-dependent manner [2]. * **C. Meglitinide analogues** (e.g., Repaglinide) are insulin secretagogues [1]. They close ATP-sensitive K+ channels in pancreatic beta cells, directly triggering insulin release [1], [2]. **High-Yield Clinical Pearls for NEET-PG:** * **Weight Loss & BP:** SGLT2 inhibitors promote weight loss (due to calorie loss via glucose) and lower blood pressure (due to osmotic diuresis). * **Cardio-Renal Protection:** They are the drugs of choice for diabetic patients with **Heart Failure** (reduced HFrEF) and **Chronic Kidney Disease (CKD)**. * **Side Effects:** The most characteristic side effects are **Genital Mycotic Infections** (due to high urinary glucose) and a rare risk of **Euglycemic Ketoacidosis**.

Q: Which drug is useful in neuronal diabetes insipidus in both children and adults when given intranasally?

Desmopressin. **Explanation:** **Desmopressin (DDAVP)** is the drug of choice for Central (Neuronal) Diabetes Insipidus (DI). It is a synthetic analog of Arginine Vasopressin (AVP) with two key modifications: deamination of cysteine and substitution of L-arginine with D-arginine. These changes result in a **selective V2 receptor agonist** action with minimal V1 (vasoconstrictor) activity. Its long duration of action (8–20 hours) and availability in an intranasal formulation make it ideal for long-term management in both children and adults. **Analysis of Incorrect Options:** * **Vasopressin (A):** This is the natural hormone. It acts on both V1 and V2 receptors, leading to significant side effects like vasoconstriction, abdominal cramps, and hypertension. It also has a very short half-life (approx. 20 minutes), making it impractical for chronic DI management. * **Lypressin (C):** A synthetic lysine-vasopressin formerly used intranasally. However, it has a shorter duration of action and more pressor (V1) side effects compared to Desmopressin, rendering it obsolete. * **Presselin (D):** This is not a standard pharmacological agent used in the treatment of Diabetes Insipidus. **NEET-PG High-Yield Pearls:** * **V2 Selectivity:** Desmopressin has a V2:V1 selectivity ratio of approximately 4000:1. * **Other Uses of Desmopressin:** Nocturnal enuresis (bedwetting), von Willebrand Disease (Type I), and Hemophilia A (as it releases Factor VIII and vWF from endothelial storage sites). * **Route of Choice:** While intranasal is common, the **oral** route is increasingly preferred for convenience, though it requires a much higher dose due to low bioavailability. * **Side Effect:** The most serious side effect of Desmopressin is **hyponatremia** (water intoxication).

Question 1

All of the following are true regarding the use of iodine, except:

Accepted Answer

Its use is contraindicated in hyperthyroidism.

Answer

It inhibits the release of thyroid hormones.

Answer

It causes acute inhibition of iodotyrosine and iodothyronine synthesis.

Answer

It can cause iodism.

Question 2

Flushing is common in patients taking which of the following oral hypoglycemic drugs with alcohol?

Accepted Answer

Chlorpropamide

Answer

Phenformin

Answer

Glibenclamide

Answer

Tolazamide

Question 3

Which dopamine agonist is used in the management of diabetes mellitus?

Accepted Answer

Bromocriptine

Answer

Metformin

Answer

Cabergoline

Answer

Vanadium salts

Question 4

Which of the sulfonylureas is the best choice in patients with chronic kidney disease?

Accepted Answer

Glipizide

Answer

Glimipride

Answer

Glibenclamide

Answer

Glyburide

Question 5

Which drug acts on V2 receptors and is used in diabetes insipidus?

Accepted Answer

Desmopressin

Answer

Telypressin

Answer

Vasopressin

Answer

Pralispressin

Question 6

Which of the following is an anti-progesterone drug?

Accepted Answer

Mifepristone

Answer

Cyproterone

Answer

Spironolactone

Answer

Tamoxifen

Question 7

Which of the following statements regarding finasteride is FALSE?

Accepted Answer

It blocks the conversion of testosterone to dihydrotestosterone.

Answer

It is used in the treatment of benign prostatic hyperplasia.

Answer

Impotence is well-documented after its use.

Answer

It is a 5-alpha reductase inhibitor.

Question 8

Which antidiabetic drug acts independently of insulin?

Accepted Answer

SGLT2 inhibitor

Answer

DPP4 inhibitor

Answer

Meglitinide analogues

Answer

GLP1 agonist

Question 9

Which drug is useful in neuronal diabetes insipidus in both children and adults when given intranasally?

Accepted Answer

Desmopressin

Answer

Vasopressin

Answer

Lypressin

Answer

Presselin

Question 10

All of the following may be used to treat hypercalcemia, except:

Accepted Answer

Normal saline with forced diuresis with thiazide

Answer

Plicamycin

Answer

Gallium nitrate

Answer

Mitramycin

Endocrine Pharmacology — MCQs

Endocrine Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?